CompletedPhase 2NCT00045435
Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fred Hutchinson Cancer Center
- Principal Investigator
- Brenda SandmaierFred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
- Intervention
- nonmyeloablative allogeneic hematopoietic stem cell transplantation(procedure)
- Enrollment
- 17 enrolled
- Eligibility
- 55 years · All sexes
- Timeline
- 2002 – 2009
Study locations (2)
- OHSU Cancer Institute, Portland, Oregon, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00045435 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.